FMP
Adicet Bio, Inc.
ACET
NASDAQ
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
0.96 USD
0.0438 (4.56%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Chen Schor BA, CPA, M.B.A.
sector
Healthcare
industry
Biotechnology
website
https://www.adicetbio.comexchange
NASDAQ
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is base...
CIK
0001720580
ISIN
US0070021086
CUSIP
007002108
Address
200 Clarendon Street
Phone
650 503 9095
Country
US
Employee
143
IPO Date
Jan 26, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
ACET Financial Summary
CIK
0001720580
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
007002108
ISIN
US0070021086
Country
US
Price
0.96
Beta
1.7
Volume Avg.
610.71k
Market Cap
79.1M
Shares
-
52-Week
0.81-3.77
DCF
3.22
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.56
P/B
-
Website
https://www.adicetbio.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ACET News
It looks like there's no news available.
